Renee Perdok

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2005 · 899 citations

Teprotumumab for the Treatment of Active Thyroid Eye Disease

Raymond S. Douglas, George J. Kahaly, Amy Patel et al. · New England Journal of Medicine · 2020 · 656 citations · Full text

Adalimumab for long‐term treatment of psoriatic arthritis: Forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trial

Dafna D. Gladman, Philip J. Mease, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2007 · 296 citations

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

Philip J. Mease, P A Ory, John T. Sharp et al. · Annals of the Rheumatic Diseases · 2008 · 264 citations · Full text

Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.

Mark C. Genovese, Philip J. Mease, G. T. D. Thomson et al. · PubMed · 2007 · 190 citations